Bevacizumab/cisplatin/pemetrexedVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1807卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79328-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：42 / 42

相关论文

共 50 条

[41] Bevacizumab/vatalanibVarious toxicities: case report
Reactions Weekly, 2016, 1585 (1) : 53 - 53
[42] Bevacizumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2021, 1872 (1) : 96 - 96
[43] Bevacizumab/sintilimabVarious toxicities: case report
Reactions Weekly, 2020, 1820 (1) : 72 - 72
[44] Bevacizumab/ramucirumabMultiple toxicities: case report
Reactions Weekly, 2021, 1859 (1) : 73 - 73
[45] Bevacizumab/paclitaxelVarious toxicities: case report
Reactions Weekly, 2021, 1844 (1) : 95 - 95
[46] Bevacizumab/paclitaxelVarious toxicities: case report
Reactions Weekly, 2017, 1650 (1) : 63 - 63
[47] Carboplatin/pemetrexedVarious toxicities: 2 case reports
Reactions Weekly, 2019, 1749 (1) : 113 - 113
[48] Amivantamab/PemetrexedVarious toxicities
Reactions Weekly, 2024, 2003 (1) : 65 - 65
[49] Lobaplatin/pemetrexedVarious toxicities: 2 case reports
Reactions Weekly, 2016, 1616 (1) : 98 - 98
[50] Bevacizumab/Cisplatin/DocetaxelHypertension: case report
Reactions Weekly, 2024, 2033 (1) : 60 - 60

← 1 2 3 4 5 →